A deletion mutation in COL17A1 in five Austrian families with generalized atrophic benign epidermolysis bullosa represents propagation of an ancestral allele

Journal of Investigative Dermatology

Volumn 110, Issue 2, 1998, Pages 170-173

  Darling, Thomas N ^c   Koh, Brian B ^c   Bale, Sherri J ^a   Compton, John G ^a   Bauer, Johann W ^b   Hintner, Helmut ^b   Yancey, Kim B ^c  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b St Johanns Spital   (Austria)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Inherited blistering disease; Polymorphism; Type XVII collagen

Indexed keywords

ALLELE; ARTICLE; AUSTRIA; BLISTER; CHROMOSOME 10Q; CROSSING OVER; DNA POLYMORPHISM; EPIDERMOLYSIS BULLOSA; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; NAIL DYSTROPHY; PRIORITY JOURNAL; SKIN ATROPHY;

EID: 0031930104     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00101.x     Document Type: Article

References (24)

1. Chavanas S, Gache Y, Tadini G, Pulkkinen L, Uitto J, Ortonne JP, Meneguzzi G: A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 109:74-78, 1997
2. Christiano AM, D'Alessio M, Paradisi M, Angelo C, Mazzanti C, Puddu P, Uitto J: A common insertion mutation in COL7A1 in two Italian families with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 106:679-684, 1996
3. Darling TN, Bauer JW, Hintner H, Yancey KB: Generalized atrophic benign epidermolysis bullosa. Adv Dermatol 13:87-119, 1997a
4. Darling TN, McGrath JA, Yee C, et al: Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 108:463-468, 1997b
5. De Laurenzi V, Rogers GR, Tarcsa E, et al: Sjögren-Larsson syndrome is caused by a common mutation in northern European and Swedish patients. J Invest Dermatol 109:79-83, 1997
6. Dib C, Faure S, Fizames C, et al: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154, 1996
7. Gatalica B, Pulkkinen L, Li K, Kuokkanen K, Ryynanen M, McGrath JA, Uitto J: Cloning of the human type XVII collagen gene (COL17A1) and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am J Hum Genet 60:352-365, 1997
8. Giudice G, Emery DJ, Diaz LA: Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243-250, 1992
9. Grubauer G, Hintner H, Klein G, Fritsch P: Erworbene, flachige riesen-navuszellnavi bei generalisierter, atrophisierender, benigner epidermolysis bullosa. Hautarzt 40:523-526, 1989
10. Hashimoto I, Schnyder UW, Anton-Lamprecht I: Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologia 152:72-86, 1976
11. Hintner H, Wolff K: Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 118:375-384, 1982
12. Hudson TJ, Clark CD, Gschwend M, Justice-Higgins E: PCR methods of genotyping. Curr Protocols Hum Genet 1:2510-2523, 1997
13. Jonkman MF, Scheffer H, Stulp R, et al: Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 88:543-551, 1997
14. Masunaga T, Shimizu H, Yee C, Borradori L, Lazarova Z, Nishikawa T, Yancey KB: The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol 109:200-206, 1997
15. McGrath JA, Gatalica B, Christiano AM, et al: Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a transmembrane hemidesmosomal collagen (COL17A1) in generalized atrophic benign epidermolysis bullosa. Nature Genet 11:83-86, 1995
16. McGrath JA, Darling T, Gatalica B, et al. A homozygous deletion mutation in the gene for the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 106:771-774, 1996a
17. McGrath JA, Gatalica B, Li K, et al: Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol 148:1787-1796, 1996b
18. McGrath JA, Kivirikko S, Ciatti S, Moss C, Christiano AM, Uitto J: A recurrent homozygous nonsense mutation within the LAMA3 gene as a cause of Herlitz junctional epidermolysis bullosa in patients of Pakistani ancestry: Evidence for a founder effect. J Invest Dermatol 106:781-784, 1996c
19. Mellerio JE, Dunnill GS, Allison W, et al: Recurrent mutations in the type VII collagen gene (COL7A1) in patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 109:246-249, 1997
20. Pohla-Gubo G, Lazarova Z, Giudice GJ, Liebert M, Grassegger A, Hintner H, Yancey KB: Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa. Exp Dermatol 4:199-206, 1995
21. Schnyder U, Anton-Lamprecht I: Zur klinik der epidermolysen mit junktionaler spaltbildung. Dermatologica 159:402-406, 1979
22. Schug MD, Mackay TFC, Aquadro CF: Low mutation rates of microsatellite loci in Drosophila melanogaster. Nature Genet 15:99-102, 1997
23. Schumann H, Hammami-Hauasli N, Pulkkinen L, et al: Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: Relation to biological and clinical phenotypes of junctional epidermolysis bullosa. Am J Hum Genet 60:1344-1353, 1947
24. Zlotogora J: High frequencies of human genetic diseases: founder effect with genetic drift or selection? Am J Med Genet 49:10-13, 1994